Protalix BioTherapeutics
PLX
$1.15
Share price
-2.54%
Change (1 day)
-58.63%
Change (1 year)
Categories
Protalix BioTherapeutics (PLX) - Cash on Hand
Cash on Hand as of December 2023 : $44.56 M
According to Protalix BioTherapeutics
's latest financial reports the company has $44.56 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Protalix BioTherapeutics - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $44.56 M | 100.9% |
| 2022-12-31 | $22.18 M | -43.11% |
| 2021-12-31 | $38.98 M | 1.14% |
| 2020-12-31 | $38.54 M | 116.64% |
| 2019-12-31 | $17.79 M | -52.94% |
| 2018-12-31 | $37.8 M | -26.1% |
| 2017-12-31 | $51.16 M | -19.15% |
| 2016-12-31 | $63.28 M | -17.14% |
| 2015-12-31 | $76.37 M | 39.45% |
| 2014-12-31 | $54.76 M | -36.61% |
| 2013-12-31 | $86.39 M | 66.04% |
| 2012-12-31 | $52.03 M | 92.72% |
| 2011-12-31 | $27 M | -24.79% |
| 2010-12-31 | $35.9 M | -55.82% |
| 2009-12-31 | $81.26 M | 90.78% |
| 2008-12-31 | $42.59 M | -31.09% |
| 2007-12-31 | $61.81 M | 169.28% |
| 2006-12-31 | $22.95 M | 384.18% |
| 2005-12-31 | $4.74 M | 740.6% |
| 2004-12-31 | $0.56 M | -22.93% |
| 2003-12-31 | $0.73 M | -9.39% |
| 2002-12-31 | $0.8 M | -11.79% |
| 2001-12-31 | $0.91 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $12.69 B | 28,378.46% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | $1.03 B | 2,215.08% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $0.28 B | 542.28% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $3.22 B | 7,139.68% | 🇮🇱 Israel |